Platelet-Rich Plasma for Peyronie's Disease
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Peyronies Disease
In brief
The purpose of this clinical trial is to evaluate the effects of Platelet-Rich Plasma (PRP) intralesional injections in men affected by Peyronie's disease (PD) in the fibrotic phase.
Key facts
- Study ID
- NCT07117955
- Run by
- Herlev Hospital
- People needed
- 84
- Starts
- 2025-09-20
- Expected to finish
- 2028-09-01
- Last updated by the study team
- 2025-08-14
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- 18 years or older
- Be able to provide written informed consent
- Diagnosis of PD without active pain and without progressive curvature over the past 3 months (fibrotic phase).
- Penile curvature of 30-95 degrees
- Clearly palpable penile plaque
You may not qualify if…
- Erectile Dysfunction unresponsive to on-demand PDE5 inhibitors
- Hourglass malformation
- Severely calcified plaques where injection is considered unfeasible
- Intrapenile plaque
- History of priapism.
- History of penile fracture.
- Previous treatment for PD with injections and/or surgery.
- Antithrombotic therapy associated with a high risk of bleeding
Where it is running
- Herlev and Gentofte University Hospital — Herlev, Denmark (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.